PRESS RELEASE published on 01/12/2023 at 14:43, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
PRESS RELEASE published on 01/12/2023 at 14:39, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: RPS Group plc
PRESS RELEASE published on 01/12/2023 at 14:34, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
PRESS RELEASE published on 01/12/2023 at 14:31, 1 year 8 months ago The Vanguard Group, Inc.: Mediclinic International plc
PRESS RELEASE published on 01/12/2023 at 14:29, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
PRESS RELEASE published on 01/12/2023 at 14:27, 1 year 8 months ago The Vanguard Group, Inc.: Biffa plc
PRESS RELEASE published on 01/12/2023 at 14:20, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 01/11/2023 at 14:39, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
PRESS RELEASE published on 01/11/2023 at 14:32, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: RPS Group plc
PRESS RELEASE published on 01/11/2023 at 14:30, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Published on 09/28/2024 at 02:06, 1 day 3 hours ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 1 day 3 hours ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day 5 hours ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 15 hours 34 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 7 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 7 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 10 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 10 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 11 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 11 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 11 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 11 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024